AIMD
NASD Ainos Inc$1.11 ↓ -0.03 (-2.97%) Trading Down from the previous close of $1.14, $0.01 below the day’s high of $1.12
- YTD change
- -32.55%
- vs 20-day SMA
- -17.07%
- vs 200-day SMA
- -33.49%
Price ranges
Price & Performance
-0.50 (-30.49%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.7% away from all-time highs of $356.25
- AIMD is down 33% since the beginning of the year
- AIMD is down 72% over the past 12 months
- AIMD is down 19% over the past 1 month
- 1% of all AIMD investors are betting against AIMD
AIMD reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -71.1%.
- Previous minute
- +$0.00
- Last hour
- +$0.01
- Last 5 days
- -16.83%
- vs 8-day SMA
- -12.12%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Ainos, Inc. operates as a dual-platform biotech company, which engages in the development of artificial intelligence-enabled olfactory sensing technologies and immune therapeutics. The firm primarily focuses on the commercialization of AI Nose, an AI-based electronic olfaction system. It continues to develop VELDONA, a low-dose oral interferon platform. The company was founded on June 26, 1984 and is headquartered in Houston, TX.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
